Improving Drug Development Speed with AI in L...

Enterprise investment in AI is rising faster than the ability to prove what it returns, leaving technology and vendor spend largely unexamined until leadership asks whether it is working. In this episode, Kellen Winters, Director of Customer Success and Business Operations for AI ...  Show more

A job title no longer tells you what a technical role actually requires, now that AI has changed how the work gets done. In this episode, Carrol Chang, CEO of Andela, unpacks how AI is reshaping technical roles, and why hiring and assessment need to shift from job titles to skill ...  Show more

Vaccine-maker Moderna is also a data company, and that’s enabling it to use AI to drastically reduce drug-development times, Chief Information Officer Brad Miller tells Bloomberg Intelligence’s Sam Fazeli and Mandeep Singh. This episode of the Tech Disruptors podcast looks at a w ...  Show more

Our guest today is Eric Boyd, the Corporate Vice President of AI at Microsoft. Eric joins us to share how organizations can leverage AI for faster development. Eric shared the benefits of using natural language to build products. He discussed the future of version control and the ...  Show more

Techbio is a field combining data, technology and biology to enhance scientific processes — and AI has the potential to supercharge the biopharmaceutical industry further. In this episode of NVIDIA’s AI Podcast, host Noah Kravitz speaks with Chris Gibson, cofounder and CEO of Rec ...  Show more

GSK’s Chief Digital and Technology Officer Shobie Ramakrishnan discusses how the company is leveraging AI and data models for vaccine development and drug discovery in this episode of Bloomberg Intelligence’s Tech Disruptors podcast. BI’s Health-Care Analyst Sam Fazeli and Techno ...  Show more